Vol 79, No 7-8 (2021)
Editorial
Published online: 2021-06-07

open access

Page views 617
Article views/downloads 559
Get Citation

Connect on Social Media

Connect on Social Media

Gene variants of the renin angiotensin aldosterone system for risk stratification in heart disease

Barry R Palmer1
Pubmed: 34125950
Kardiol Pol 2021;79(7-8):728-729.

Abstract

Not available

References

  1. Cambien F, Poirier O, Lecerf L, et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature. 1992; 359(6396): 641–644.
  2. Ellis KL, Palmer BR, Frampton CM, et al. Genetic variation in the renin-angiotensin-aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease. J Hum Hypertens. 2013; 27(4): 237–244.
  3. Buraczyńska M, Pijanowski Z, Spasiewicz D, et al. Renin-angiotensin system gene polymorphisms: assessment of the risk of coronary heart disease. Kardiol Pol. 2003; 58(1): 1–9.
  4. Singh M, Singh AK, Pandey P, et al. Molecular genetics of essential hypertension. Clin Exp Hypertens. 2016; 38(3): 268–277.
  5. Qiu Ye, Zhao YB, Wang Q, et al. Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2. Microbes Infect. 2020; 22(4–5): 221–225.
  6. Devaux CA, Rolain JM, Raoult D. ACE2 receptor polymorphism: susceptibility to sars-cov-2, hypertension, multi-organ failure, and COVID-19 disease outcome. J Microbiol Immunol Infect. 2020; 53(3): 425–435.
  7. Palmer BR, Jarvis MD, Pilbrow AP, et al. Angiotensin-converting enzyme 2 A1075G polymorphism is associated with survival in an acute coronary syndromes cohort. Am Heart J. 2008; 156(4): 752–758.
  8. Burrell LM, Harrap SB, Velkoska E, et al. The ACE2 gene: its potential as a functional candidate for cardiovascular disease. Clin Sci (Lond). 2013; 124(2): 65–76.
  9. Gorący I, Peregud-Pogorzelska M, Safranow K, et al. Key genetic variants in the renin-angiotensin system and left ventricular mass in a cohort of Polish patients with heart failure. Kardiol Pol. 2021; 79(7-8): 765–772.
  10. Roberts R, Chang CC, Hadley T. Genetic risk stratification: a paradigm shift in prevention of coronary artery disease. JACC Basic Transl Sci. 2021; 6(3): 287–304.
  11. Samani NJ, Erdmann J, Hall AS, et al. WTCCC and the Cardiogenics Consortium. Genomewide association analysis of coronary artery disease. N Engl J Med. 2007; 357(5): 443–453.
  12. McPherson R, Pertsemlidis A, Kavaslar N, et al. A common allele on chromosome 9 associated with coronary heart disease. Science. 2007; 316(5830): 1488–1491.
  13. Miyazawa K, Ito K. The evolving story in the genetic analysis for heart failure. Front Cardiovasc Med. 2021; 8: 646816.
  14. Martinez HR, Beasley GS, Miller N, et al. Clinical insights into heritable cardiomyopathies. Front Genet. 2021; 12: 663450.